Breaking News, Promotions & Moves

Paragon Bioservices Appoints New CTSO

Bolsters leadership ranks to support late-stage clinical and commercial biopharma manufacturing

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Paragon Bioservices, a biologics contract development and manufacturing organization (CDMO), has appointed Thomas VanCott as chief technology and strategy officer (CTSO), along with several key promotions and new hires.   “We are thrilled to welcome Tom into the CTSO role,” said Pete Buzy, president and chief executive officer, Paragon. “As a seasoned biopharmaceutical executive with a strong track record of success and deep experience in strategy, research and development and manufa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters